Results 181 to 190 of about 229,451 (392)

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

open access: yesNew England Journal of Medicine, 2010
P. Kantoff   +12 more
semanticscholar   +1 more source

Rehumanizing Higher Education: Fostering Humanity in the Era of Machine Learning

open access: yesNew Directions for Teaching and Learning, EarlyView.
ABSTRACT Recent advancements in artificial intelligence (AI) have raised contentious questions and spawned divided opinions regarding the future of education. The polarization it brings to the academy seems to be breaking between the soft and hard disciplines and is reminiscent of the Science Wars of the 1990s. This chapter highlights the philosophical
Joseph Carver, Samba Bah
wiley   +1 more source

Unveiling the potential of emerging microRNA panels as diagnostic biomarkers for prostate cancer: A review

open access: yesUroPrecision, EarlyView.
Abstract Prostate cancer (PCa) is a multifaceted disease that envelops 1.41 million new cases globally. It is the second most common cancer reported in men. Its heterogeneity and indolent growth, coupled with incompetent early screening methods such as serum prostate‐specific antigen level estimations and digital rectal examinations, contribute to its ...
Anveshika Manoj   +2 more
wiley   +1 more source

Metastatic intrigue: Penile involvement in prostate cancer with neuroendocrine differentiation—A case report

open access: yesUroPrecision, EarlyView.
Abstract Background Neuroendocrine carcinoma of the prostate is a rare tumor subtype found in the spectrum of prostate cancer, and is more difficult to detect, due to the low prostate‐specific antigen values associated with it. A high degree of suspicion is hence needed to arrive at the diagnosis in such cases.
Uttam Kumar Mete   +3 more
wiley   +1 more source

Abiraterone plus Prednisone in Metastatic, Castration‐Sensitive Prostate Cancer

open access: yesNew England Journal of Medicine, 2017
K. Fizazi   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy